About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
As policymakers look to reduce health care costs, provider-administered medicines have been increasingly singled out as an area of interest, even though they account for less than 5% of total health care spending. In this report, a follow-up to PhRMA's Follow the Dollar Report of 2017, industry experts explain how the medicine distribution system works, how payments flow between stakeholders, and how factors such as hospital consolidation, site-of-service payment differentials, and the 340B Drug Discount Program affect the cost of provider-administered medicines.
Report
Cost and Value
Follow the Dollar Part II
Follow the Dollar Part II image